The US- FDA Launches New Accelerating Rare disease Cures (ARC) Program
On May 2022, the US-FDA’s Center for Drug Evaluation and Research (CDER) announced the launch of the new Accelerating Rare disease Cures (ARC) Program.
Tag: CDER ARC Program
On May 2022, the US-FDA’s Center for Drug Evaluation and Research (CDER) announced the launch of the new Accelerating Rare disease Cures (ARC) Program.
Copyright ©2023 Global Regulatory Partners